News Column

NEOSTEM, INC. FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 3, 2014

Item 8.01. Other Events.

Concurrently with the filing of this Current Report on Form 8-K, NeoStem will be filing a prospectus supplement to NeoStem's effective shelf Registration Statement on Form S-3 (File No. 333-183543) pursuant to Rule 424(b)(5) under the Securities Act (the "Prospectus Supplement"), which Prospectus Supplement shall cover the issuance of shares of NeoStem common stock pursuant to NeoStem's previously-announced Common Stock Purchase Agreement, dated as of March 10, 2014, with Aspire Capital Fund, LLC (the "2014 Purchase Agreement"). The description of the 2014 Purchase Agreement appearing in NeoStem's Annual Report on Form 10-K for the fiscal year ended December 31, 2013 under the caption "Item 9B. Other Information" is incorporated herein by reference.

The legality of the shares of NeoStem common stock to be issued pursuant to the 2014 Purchase Agreement has been passed upon by Lowenstein Sandler LLP, Roseland, New Jersey. A copy of Lowenstein Sandler LLP's opinion, which is to be incorporated by reference into to Prospectus Supplement, is filed with this Current Report on Form 8-K as Exhibit 5.1.

Item 9.01. Financial Statements and Exhibits.

The following exhibits are filed with this Current Report on Form 8-K:


Exhibit No. Description

5.1 Opinion of Lowenstein Sandler LLP 23.1 Consent of Lowenstein Sandler LLP (included in Exhibit 5.1)


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters